Acute lung injury following gadolinium contrast: a case report

ARDS related to gadolinium contrast is rare and there have only been five previously reported cases in adults. We describe the first case to our knowledge of pediatric acute lung injury related to gadolinium contrast administration. We report on a previously healthy 10-year-old boy in our Pediatric Intersive Care Unit who was recovering from staphylococcus aureus sepsis when he developed hypoxemic respiratory failure three hours after intravenous administration of gadolinium contrast for brain magnetic resonance imaging. A chest radiograph demonstrated new bilateral opacities consistent with pulmonary edema and ARDS. The patient was treated with bilevel positive airway pressure, steroids, antibiotics, and diuretics. Over the next three days, the patient clinically recovered with radiographic improvement of his lung findings. The patient was discharged home after a nearly 1-month hospitalization. Acute lung injury related to gadolinium contrast is rare, with only five previously reported cases in adults and none in children. The longer duration to onset of symptoms in our patient, along with the lack of anaphylactic symptoms, sets this case apart from previously reported cases or contrast-related ARDS and may suggest a different underlying mechanism than previously described. Pediatric intensive care providers should be aware of this potential complication in children.

[1]  Hsu-Chung Liu,et al.  A rare case of acute respiratory distress syndrome caused by use of gadolinium‐based magnetic resonance imaging contrast media , 2019, Respirology case reports.

[2]  B. Wagner,et al.  Gadolinium-based contrast agents: why nephrologists need to be concerned , 2019, Current opinion in nephrology and hypertension.

[3]  L. Sağlam,et al.  Acute respiratory distress syndrome after the use of gadolinium contrast agent , 2018, Respiratory medicine case reports.

[4]  D. Podberesky,et al.  Gadolinium-based contrast agents in children , 2018, Pediatric Radiology.

[5]  D. Tran,et al.  Œdème pulmonaire non cardiogénique fatal après injection de gadolinium , 2017 .

[6]  J. Garcia,et al.  Dysregulated Nox4 ubiquitination contributes to redox imbalance and age-related severity of acute lung injury. , 2017, American journal of physiology. Lung cellular and molecular physiology.

[7]  Vidya Chidambaran,et al.  Propofol: A Review of its Role in Pediatric Anesthesia and Sedation , 2015, CNS Drugs.

[8]  E. Nam,et al.  Acute Respiratory Distress Syndrome after the Use of Gadolinium Contrast Media , 2015, Yonsei medical journal.

[9]  S. Belknap,et al.  Pediatric nephrogenic systemic fibrosis is rarely reported: a RADAR report , 2014, Pediatric Radiology.

[10]  H. Koçoğlu,et al.  Magnetic resonance imaging contrast agent related pulmonary edema: a case report. , 2012, European review for medical and pharmacological sciences.

[11]  C. Su,et al.  Acute respiratory distress syndrome and lung injury: Pathogenetic mechanism and therapeutic implication. , 2012, World journal of critical care medicine.

[12]  P. Marckmann,et al.  Multiorgan gadolinium (Gd) deposition and fibrosis in a patient with nephrogenic systemic fibrosis--an autopsy-based review. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[13]  G. Deray,et al.  Renal safety of gadolinium-based contrast media in patients with chronic renal insufficiency. , 2009, Radiology.

[14]  D. Liu,et al.  ENDOTOXIN‐INDUCED ACUTE LUNG INJURY IS ENHANCED IN RATS WITH SPONTANEOUS HYPERTENSION , 2007, Clinical and experimental pharmacology & physiology.

[15]  C. Shih,et al.  Neurogenic pulmonary edema. , 1987, American family physician.